IN this issue of Anesthesiology, Marin-Corral et al.1
report a reduction of several markers of oxidative and nitroxidative stress in the diaphragm and limb muscles of rats exposed to ventilator-induced lung injury (VILI). This finding initially seems counterintuitive because VILI is thought to induce a systemic inflammatory state,2
which should lead to increased, rather than decreased, oxidative stress also in tissues other than the lung. In this editorial, we will briefly review the basic biochemistry of the oxidative markers measured by Marin-Corral et al.
to provide some context to these observations, highlight the main results of this study, and define a framework for future investigations of the skeletal muscle effects associated with VILI.
Reactive oxygen species (ROS) are produced physiologically during cellular respiration. Although 95% of oxygen is reduced to H2
O and CO2
during oxidative phosphorylation, 5% is reduced to superoxide anion radical (O2·–
) by capturing a single electron from the mitochondrial transport chain (fig. 1
is reduced to hydrogen peroxide (H2
) both chemically and by enzymes such as superoxide dismutase (SOD), and H2
is converted to hydroxyl radicals (·
OH). ROS radicals, and in particular ·
OH, oxidize proteins, lipids, and nucleic acids, altering the structure and function of these entities.
ROS production increases significantly above physiologic levels during inflammatory states. In their study, Marin-Corral et al.
measured two end products of ROS-mediated oxidation: protein carbonyls3,4
and malondialdehyde (MDA)-protein adducts.5
Protein carbonyls are formed by several mechanisms including oxidation of primary (serine) or secondary (treonine) alcohol amino acid residues. MDA, instead, is a product of peroxidation of polyunsaturated fatty acids by ROS. It is highly reactive and binds covalently to proteins by alkylating several amino acid residues. Studies in vitro
have shown that the levels of MDA correlate with those of MDA-protein adducts.5
Reactive nitrogen species (RNS) include nitric oxide (·
NO) and its oxidation products with ROS. RNS can lead to both nitrosation (R-N=O) and nitration (R-NO2
) of amino acid residues (R). Tyrosine nitration has been recognized as a major posttranslational protein modification in cardiovascular6
diseases and is often used as a biomarker of “nitroxidative stress.”8
The two main pathways for tyrosine nitration are as follows6,8
): (1) reaction of ·
NO with O2·–
to generate peroxynitrite anion (ONOO–
), a highly oxidizing and nitrating compound that reacts with CO2
to yield nitrogen dioxide (NO2·
) and carbonate radical (CO3·–
), which oxidizes tyrosine to tyrosyl radical. Tyrosyl radical is then nitrated by NO2·
to yield 3-nitrotyrosine; (2) reaction of nitrite (NO2–
, generated by oxidation of ·
NO with molecular oxygen) with hemeperoxidases (e.g.
, myeloperoxidase) and H2
to yield tyrosyl radical and NO2·
. As in the first pathway, NO2·
then adds to the tyrosyl radical to generate 3-nitrotyrosine. This second pathway seems to be the main venue for tyrosine nitration in vivo
, especially in heme-rich tissues such as skeletal muscle.9
ROS and RNS pathways are intimately interwoven as O2·– and H2O2 play a crucial role in the protein oxidation that forms the basis for tyrosine nitration.
Protection from ROS
The two main mechanisms of protection from ROS are SOD and catalase. SOD converts O2·–
, and catalase converts H2
to water. These metalloproteins act as antioxidants. In this study,1
skeletal muscle and lung levels of catalase and the mitochondrial form of SOD (Mn-SOD) were measured to determine the level of protection from ROS.
VILI and Oxidative Stress
Because VILI has been postulated to initiate and propagate a systemic inflammatory response,2
and ROS and RNS are critically important mediators of inflammatory states, one might expect that oxidative stress is increased during VILI. In the investigation by Marin-Corral et al.
, inflammation occurred in the lungs of rats exposed to VILI, because inflammatory cell infiltration and MDA-protein adducts increased in their lungs compared with nonmechanically ventilated controls. Moreover, protection from ROS seemed to decrease as Mn-SOD and catalase levels were lower than in the lungs of controls. However, instead of seeing evidence of increased oxidative stress in skeletal muscle, protein carbonyls, MDA-protein adducts, and protein tyrosine nitration decreased in skeletal muscle.
How can we explain these observations? One possibility is that, because of its hemodynamic effect, VILI impairs perfusion to peripheral tissues, including skeletal muscle, making them ischemic and limiting the amount of ROS that can form, akin to the ischemic phase of ischemia–reperfusion injury where the bulk of ROS is formed during the reperfusion rather than the ischemic phase. However, markers of oxidative stress as well as nitrotyrosine have been shown to increase within 40 min of renal ischemia even without reperfusion.10
Furthermore, as Marin-Corral et al.
point out, protein oxidation and nitration were also reduced in the moderate tidal volume group, which did not experience the hypotension and acidosis of the group receiving the higher tidal volume. Consequently, hypoperfusion is unlikely to be the sole explanation for these findings.
A more intriguing explanation is that the reduction in protein tyrosine nitration reflects an increase, rather than a decrease, in oxidative stress. As Bian et al.9
elegantly showed, the relationship between H2
concentration and tyrosine nitration (and, to a lesser extent, also carbonyl formation) is biphasic: nitration increases steeply up to 0.5 mm H2
but decreases for higher concentrations of H2
. This is probably because excess H2
causes suicide inactivation of peroxidases and degradation of heme in metalloproteins such as myoglobin.9
Consequently, tyrosine nitration through the second pathway is expected to decrease at high concentrations of H2
. Inactivation of peroxidase by excess H2
could also account for the apparently contradictory finding of decreased protein nitroxidation despite increased leukocyte infiltration in skeletal muscle, which would be expected to lead to increased tyrosine nitration by activation of the pathway by myeloperoxidase. In fact, all these biochemical assays measure reaction by-products of ROS and RNS, which may not necessarily correlate with the level of the reactive species themselves (see fig. 2B of Reference 9
Finally, it is possible that oxidative and nitroxidative stress are simply not part of the early VILI-induced molecular changes in skeletal muscle, as the authors suggest.
What clinical inferences, if any, can we draw from this experiment? We know that loss of aeration in Acute Respiratory Distress Syndrome (ARDS) is highly heterogeneous11
and the distribution of tidal volume uneven, such that very high regional stress and strain can develop in the ARDS lung even with clinically acceptable tidal volumes.12
The value of studying the effect of these high levels of strain in normal lungs is to isolate the contribution of VILI to these biochemical phenomena while eliminating the confounding effect of other sources of lung injury. In this respect, studies in normal lungs provide “proof-of-concept” and are just as valuable as experiments in models of ARDS in which a second insult is imposed on the lung. It is quite possible that levels of strain comparable with those imposed on the whole lung in this study develop on a regional basis in ARDS. Thus, the results of this study suggest that VILI-induced skeletal muscle oxidative imbalance could contribute to muscle weakness and potentially to critical-illness myopathy in ARDS. If the observed decrease in protein oxidation was a marker of decreased ROS production, a reduction in muscle contractility could be expected because certain levels of ROS are required for optimal contractility.13
If instead the decrease in protein oxidation and nitration was “paradoxically” a marker of increased ROS production, a reduction in contractility might be expected as a result of the inflammatory process associated with excessive ROS.
Future studies should clarify the relationship between levels of the primary noxious stimuli (e.g., ROS or RNS), their reaction by-products (e.g., protein carbonyls or nitrotyrosine), and the ensuing functional impairment (e.g., reduced muscle contractility). How to interpret these associations and whether they have pathogenetic significance, however, require a focused assessment of the causal relation between the biomarker and the functional or structural abnormality. The big question that remains is whether the measured oxidative and nitroxidative protein changes induced by VILI affect skeletal muscle function and how this effect occurs.
The authors thank Claus U. Niemann, M.D. (Associate Professor of Anesthesia and Surgery, Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, California), for his critique of the manuscript.
Guido Musch, M.D.
Jeanine P. Wiener-Kronish, M.D.
Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. email@example.com
1. Marín-Corral J, Martínez-Caro L, Lorente JA, de Paula M, Pijuan L, Nin N, Gea J, Esteban A, Barreiro E: Redox balance and cellular inflammation in the diaphragm, limb muscles, and lungs of mechanically ventilated rats. Anesthesiology 2010; 112:384–94
2. Slutsky AS, Tremblay LN: Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 1998; 157:1721–5
3. Chevion M, Berenshtein E, Stadtman ER: Human studies related to protein oxidation: Protein carbonyl content as a marker of damage. Free Radic Res 2000; 33(suppl):S99–108
4. Stadtman ER, Levine RL: Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 2003; 25:207–18
5. Hartley DP, Kroll DJ, Petersen DR: Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: Detection of 4-hydroxynonenal- and malondialdehyde-protein adducts. Chem Res Toxicol 1997; 10:895–905
6. Peluffo G, Radi R: Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 2007; 75:291–302
7. Van der Vliet A, Eiserich JP, Shigenaga MK, Cross CE: Reactive nitrogen species and tyrosine nitration in the respiratory tract. Am J Respir Crit Care Med 1999; 160:1–9
8. Radi R: Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA 2004; 101:4003–8
9. Bian K, Gao Z, Weisbrodt N, Murad F: The nature of heme/iron-induced protein tyrosine nitration. Proc Natl Acad Sci USA 2003; 100:5712–7
10. Walker LM, York JL, Imam SZ, Ali SF, Muldrew KL, Mayeux PR: Oxidative stress and reactive nitrogen species generation during renal ischemia. Toxicol Sci 2001; 63:143–8
11. Maunder RJ, Schuman WP, McHugh JW, Marglin SI, Butler JB: Preservation of normal lung regions in the adult respiratory distress syndrome. Analysis by computed tomography. JAMA 1986; 255:2463–5
12. Mead J, Takishima T, Leith D: Stress distribution in lungs: A model of pulmonary elasticity. J Appl Physiol 1970; 28:596–608
13. Reid MB, Khawli FA, Moody MR: Reactive oxygen in skeletal muscle. III. Contractility of unfatigued muscle. J Appl Physiol 1993; 75:1081–7
© 2010 American Society of Anesthesiologists, Inc.